Research shows sex differences in cardiac outcomes for dialysis patients

Lead author of UC study receiving international recognition for her work

An interdisciplinary study involving eight University of Cincinnati College of Medicine experts has found significant sex differences in cardiovascular outcomes in patients with kidney failure. 

The study’s lead author will receive an international award for her work, which was published in the Journal of the American Heart Association

In one of the largest studies of its kind, researchers analyzed data from more than 500,000 patients undergoing dialysis in the United States and found that women have a higher risk of heart failure and stroke than men. However, women have a lower overall risk of cardiovascular death and death from all causes.

“To the best of our knowledge, it’s the first time these findings of a higher risk of cardiovascular events in women than men among those with kidney failure who are on dialysis have been reported in literature,” said Silvi Shah, MD, MS, FASN, FACP, an associate professor in UC’s Division of Nephrology and Hypertension in the Department of Internal Medicine and the study’s principal investigator. 

Researchers found women undergoing dialysis have a 14% higher risk of cardiovascular events, including a 16% higher risk of heart attack and a 31% higher risk of stroke than men. 

As for why, Shah and her collaborators have a number of theories.

One is the role of estrogen. It’s known that its protective properties decline in women undergoing dialysis, as they typically enter menopause years earlier than their healthy counterparts.

“Women also tend to receive less preventative kidney care, which can lead to the need for dialysis in the first place,” said Shah. “And women who suffer strokes tend to receive less care for them.”

Shah said women experiencing kidney failure also tend to start dialysis later than men. She added that when they do start dialysis, they tend to receive fewer hours of treatment than men.

Plus, women undergoing dialysis have higher rates of diabetes than men who are undergoing dialysis.  

As for why women in dialysis suffer cardiac events more often than men but survive, Shah said more research needs to be conducted. 

“We don’t know the real reason,” she said.

Silvi Shah, MD, on the medical campus of the University of Cincinnati

Silvi Shah, MD, on the medical campus of the University of Cincinnati. Photo/Colleen Kelley/University of Cincinnati.

Her team believes it could be due to misdiagnoses or mismanagement of treatments.

“Women have to be treated differently when it comes to their heart health,” said Shah. “The study revealed significant sex differences in cardiovascular health. These disparities between the sexes and disparities in care point to the need for more personalized heart care for women,” said Shah.

She said the research revealed only some of what doctors need to keep in mind when monitoring a female patient’s cardiovascular health.

“Providers need to re-evaluate how they approach prevention and education on heart disease and stroke,” said Shah. “But this study underscores the importance of promoting overall heart health and healthy living, particularly for women who have kidney failure and are on dialysis.”

It also revealed that more research is needed on women undergoing dialysis — and it’s already in the works for Shah. 

She is planning a study to better understand the pathophysiology leading to more frequent cardiovascular events in women with kidney failure.

Shah’s study collaborators included Annette Christianson, MS, research associate in the Department of Biostatistics, Health Informatics and Data Sciences; Anthony Leonard, PhD, adjunct associate professor and biostatistician in the Department of Biostatistics, Health Informatics and Data Sciences; Karthikeyan Meganathan, PhD, adjunct assistant professor and data analyst in the Department of Biostatistics, Health Informatics and Data Sciences; Mark Mitsnefes, MD, professor in the Department of Pediatrics and pediatric nephrologist at Cincinnati Children’s Hospital Medical Center; Jack Rubinstein, MD, professor in the Division of Cardiovascular Health and Disease in the Department of Internal Medicine; Daniel Schauer, MD, MSc, adjunct associate professor in the Department of Internal Medicine; and Charuhas Thakar, MD, volunteer professor in the Division of Nephrology and Hypertension in the Department of Internal Medicine.

Shah’s research was supported by a career development award from the National Heart, Lung and Blood Institute of the National Institutes of Health.

An award for her work

For her work, Shah is receiving the Dr. Nanette K. Wenger Research Goes Red Award for best scientific publication on cardiovascular disease and stroke in women published in an American Heart Association Journal. 

The award is given in recognition of the best research article published during the previous year in any of the association’s 14 peer-reviewed, scientific journals. Shah’s work was selected out of 137 submissions from 18 different countries. 

She will receive the award and present the winning research at the American Heart Association’s Scientific Sessions on Nov. 16 in Chicago.

Featured image at top: A health care worker wearing blue latex gloves prepares a patient for hemodialysis. Photo/istock/Dobri Dobrev.

Related Stories

1

UC faculty and staff among Rising Star leadership honorees

January 5, 2026

Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.

2

What's behind the mysterious rise of migraines?

January 5, 2026

Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.

3

Top six 2025 nephrology drug approvals

January 5, 2026

“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.